ArticleOncology2022
Estimating Long-Term Survival Outcomes for Tumor-Agnostic Therapies: Larotrectinib Case Study.
Andrew Briggs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this paperpooled itcites it
ArticleOncology2022
Andrew Briggs et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.